missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Conduritol B epoxide

Artikelnummer. 18788696
Ansicht ändern
Click to view available options
Menge:
5 mg
25 mg
Packungsgröße:
25 Milligramm
5 Milligramm
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge Packungsgröße
18788696 5 mg 5 Milligramm
18718546 25 mg 25 Milligramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Artikelnummer. 18788696 Lieferant R&D Systems™ Lieferanten-Nr. 7056/5
  • ONLINE EXCLUSIVE PRICE
    171.00 CHF
    161.70 CHF / 5 Milligramm
    Sparen 9.30 CHF
    5% Rabatt
 Eingeschränkter Artikel
Verfügbar ab: 30-10-2026
Zum Warenkorb hinzufügen
Zum Warenkorb hinzufügen

missing translation for 'validMainframeMsg'

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

A Tocris product, part of R&D Systems. Irreversible glucocerebrosidase (β-glucosidase) inhibitor; used to generate Gaucher disease models

Conduritol B epoxide is an irreversible glucocerebrosidase (GBA) inhibitor (Ki = 53 μM; IC50 = 4.28 - 9.49 μM). Also inhibitis lysosomal α-glucosidase. Used to generate animal models of Gaucher disease. Accelerates recovery of peripheral nerve injury in mice. Preserves motoneurons and ganglioside distribution at the neuromuscular junction, delays disease onset and improves motor function in a mouse ALS model.
TRUSTED_SUSTAINABILITY

Specifications

Chemischer Name oder Material DL-1,2-Anhydro-myo-Inositol
CAS 6090-95-5
Menge 5 mg
Produktlinie Tocris
Ziel Glycosylase Inhibitors
Summenformel C6H10O5
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.